Ian Flinn - Dissemin

Papers authored by Ian Flinn

This paper was not found in any repository, but could be made available legally by the author.

2012 Javier Pinilla-Ibarz, Ian Flinn

The expanding options for front-line treatment in patients with newly diagnosed CML

Upload

Ines M. Macias-Perez, Ian W. Flinn

B-Cell Receptor Pathobiology and Targeting in NHL

Upload

This paper is made freely available by the publisher.

Bruce D. Cheson, John C. Byrd, Kanti R. Rai, Neil E. Kay, Susan M. O'Brien, Ian W. Flinn

, Adrian Wiestner, Thomas J. Kipps

Novel Targeted Agents and the Need to Refine Clinical End Points in Chronic Lymphocytic Leukemia

Download from doi.org

This paper is available in a repository.

John C. Byrd, Thomas J. Kipps, Ian W. Flinn

, Maureen Cooper, Olatoyosi Odenike, Jennifer Bendiske, John Rediske, Sanela Bilic, Jyotirmoy Dey, Johan Baeck, Susan O’Brien

Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia

Download from europepmc.org

R. A. Larson, A. Hochhaus, T. P. Hughes, R. E. Clark, G. Etienne, D.-W. Kim, I. W. Flinn

, M. Kurokawa, B. Moiraghi, R. Yu, R. E. Blakesley, N. J. Gallagher, G. Saglio, H. M. Kantarjian

Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up

Download from www.nature.com

Shaji Kumar, Ian Flinn

, Paul G. Richardson, Parameswaran Hari, Natalie Callander, Stephen J. Noga, A. Keith Stewart, Francesco Turturro, Robert Rifkin, Jeffrey Wolf, Jose Estevam, George Mulligan, Hongliang Shi, Iain J. Webb, S. Vincent Rajkumar

Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma

Download from ashpublications.org

2011 Ian W. Flinn

CD37: The comeback kid

Download from www.bloodjournal.org

Hagop M. Kantarjian, Andreas Hochhaus, Giuseppe Saglio, Carmino De Souza

, Ian W. Flinn

, Leif Stenke, Yeow-Tee Goh, Gianantonio Rosti, Hirohisa Nakamae, Neil J. Gallagher, Albert Hoenekopp, Rick E. Blakesley, Richard A. Larson, Timothy P. Hughes

Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial

Upload

Mitchell R. Smith

, Donna Neuberg, Ian W. Flinn

, Michael R. Grever, Hillard M. Lazarus, Jacob M. Rowe, Gordon Dewald, John M. Bennett, Elisabeth M. Paietta, John C. Byrd, Mohamad A. Hussein, Frederick R. Appelbaum, Richard A. Larson, Mark R. Litzow, Martin S. Tallman

Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997

Download from www.bloodjournal.org

Douglas E. Gladstone, Javier Bolaños-Meade, Carol Ann Huff, Marianna Zahurak, Ian Flinn

, Ivan Borrello, Leo Luznik, Ephraim Fuchs, Yvette Kasamon, William Matsui

, Jonathan Powell, Hyam Levitsky, Robert A. Brodsky, Richard Ambinder, Richard J. Jones and 1 other authors

High-dose cyclophosphamide and rituximab without stem cell transplant: A feasibility study for low grade B-cell, transformed and mantle cell lymphomas

Download from europepmc.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

I. W. Flinn

Advances in llm: B-cell receptor inhibitors in chronic Lymphocytic Leukemia

Upload

2010 James R. Berenson, Ori Yellin, John Crowley, Adel Makary, Donald S. Gravenor, Hank H. Yang, Gargi H. Upadhyaya, Ian W. Flinn

, Harry Staszewski, Natasha M. Tiffany, Shamel Sanani, Charles M. Farber, Neil Morganstein, Vanessa Bolejack, Youram Nassir and 4 other authors

Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid

Download from onlinelibrary.wiley.com

Sk K. Kumar, I. Flinn

, Sj J. Noga, P. Hari, R. Rifkin, N. Callander, M. Bhandari, Jl L. Wolf, C. Gasparetto, A. Krishnan, D. Grosman, J. Glass, Ea A. Sahovic, H. Shi, Ij J. Webb and 2 other authors

Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study

Download from www.nature.com

John D. Hainsworth, Ian W. Flinn

, David R. Spigel, Bobby L. Clark, Paula L. Griner, Elizabeth R. Vazquez, Habib H. Doss, Dianna Shipley, Luis A. Franco, Howard A. Burris, F. Anthony Greco

Brief-Duration Rituximab/Chemotherapy Followed by Maintenance Rituximab in Patients With Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy: A Phase II Trial of the Sarah Cannon Oncology Research Consortium

Upload

2009 Y. L. Kasamon, R. J. Jones, R. A. Brodsky, E. J. Fuchs, W. Matsui

, L. Luznik, J. D. Powell, A. L. Blackford, A. Goodrich, C. D. Gocke, R. A. Abrams, R. F. Ambinder, I. W. Flinn

Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma

Download from www.ncbi.nlm.nih.gov

John C. Byrd, Thomas J. Kipps, Ian W. Flinn

, Januaro Castro, Thomas S. Lin, William Wierda, Nyla Heerema, James Woodworth, Steve Hughes, Shabnam Tangri, Sarah Harris, Dee Wynne, Arturo Molina, Bryan Leigh, Susan O'Brien

Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

Download from www.bloodjournal.org

Distributing this paper is prohibited by the publisher

Thomas S. Lin, Wendy Stock, Huiping Xu, Mitch A. Phelps, Margaret S. Lucas, Sara K. Guster, Bruce R. Briggs, Carolyn Cheney, Pierluigi Porcu, Ian W. Flinn

, Michael R. Grever, James T. Dalton, John C. Byrd

A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia

Upload

Bin He, Richard L. Wahl, George Sgouros, Yong Du, Heather Jacene, Wayne R. Kasecamp, Ian Flinn

, Richard J. Hammes, Jay Bianco, Brad Kahl, Eric C. Frey

Comparison of organ residence time estimation methods for radioimmunotherapy dosimetry and treatment planning-patient studies: Residence time estimation methods-patient studies

Upload

2008 Bin He, Yong Du, Bin He, Richard L. Wahl, Yong Du, George Sgouros, Heather Jacene, Ian Flinn

, Eric C. Frey

Comparison of Residence Time Estimation Methods for Radioimmunotherapy Dosimetry and Treatment Planning—Monte Carlo Simulation Studies

Download from www.ncbi.nlm.nih.gov

Ian W. Flinn

, Jesus G. Berdeja

Blood and Bone Marrow Transplantation for Patients with Hodgkin’s and Non-Hodgkin’s Lymphoma

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Ian Flinn